PYC Therapeutics | PYC - Ebitda

Stock Price
1.50
Daily Change
-0.01 -0.33%
Monthly
-9.12%
Yearly
22.54%
Q1 Forecast
1.47

PYC Therapeutics reported AUD-24.29M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Avita Medical AUD -21.9M 12.04M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025